Le Lézard
Classified in: Environment, Health
Subject: CCA

/R E P E A T -- Claigan Webinar - Mastering PFAS Data Reporting for EPA Compliance/


Providing Real-World Guidance

OTTAWA, ON, March 12, 2024 /PRNewswire/ - On March 20, Claigan Environmental Inc. (www.claigan.com) will be hosting an informative webinar dedicated to navigating the complexities of reporting PFAS data to the EPA. Join us to gain practical insights into the reporting process.

On October 11, 2023, the US EPA finalized its regulations for PFAS reporting, outlining the requirements for chemical and article manufacturers within the CDX reporting system.  Manufacturers and importers are obligated to submit data dating back to 2011.

Claigan's webinar will provide detailed guidance on how to meet these reporting requirements, with a specific focus on practical solutions, including aligning chemical data with product volumes from 2011 and onwards.

Topics to include:

Note - due to the expected demand, there will be two (2) webinar schedule on March 20.

Webinars - Reporting PFAS TSCA Data 
Date: 20 March 2024
Time: 10am and 2pm
Duration: 1 hour including Q&A
To Register:
10am - https://us06web.zoom.us/webinar/register/WN_ByR6zX6iRMKvdb06NUWcQw
2pm - https://us06web.zoom.us/webinar/register/WN_HZjx-HmaSF2vIOo0DkdK_Q 

or on Claigan's Website at www.claigan.com/webinars

About Claigan Environmental (www.claigan.com)

Claigan is the leading provider in restricted materials compliance.  Claigan has tested thousands of products for PFAS, REACH, POP, TSCA, Prop 65, and related global compliance. Claigan is an ISO 17025 certified laboratory and is dedicated to providing practical solutions for supply chain due diligence and social responsibility. 

At Claigan, our philosophy is simple: More Results, Less Journey.

SOURCE Claigan Environmental Inc.


These press releases may also interest you

at 22:03
The report titled "Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization &...

at 20:59
Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at the April ASCO Plenary Series, which was held online. Prof. Yuankai Shi, chief physician of...

at 20:08
Waverley Pharma Inc. ("Waverley Pharma" or the "Company") , a Canadian pharmaceutical company, is announcing a business update. As mentioned in the previous business update dated August 2, 2023, opportunities Waverley Pharma envisioned of marketing...

at 19:46
Feeding Matters is proud to celebrate the 6th annual PFD Awareness Month, which is recognized around the globe. This designation, initiated by Feeding...

at 18:57
Korea Ginseng Corp. US (KGCUS) aka JungKwanJang held a dedicated international seminar session on "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights'' at the International Conference on the Science of Botanicals (ICSB) hosted by the...

at 18:33
More than 500 life science professionals gathered at Momentum Labs | Alachua for BioFlorida's 19th Annual Celebration of Biotechnology. This lively community event offered attendees the opportunity to connect with industry leaders, learn about new...



News published on and distributed by: